Document is current
Any future updates will be listed below
-
Authors
Mastrorosa, Ilaria
Cozzi-Lepri, Alessandro
Matusali, Giulia
Colavita, Francesca
Lanini, Simone
Rueca, Martina
Oliva, Alessandra
Berno, Giulia
Vergori, Alessandra
Rosati, Silvia
Paulicelli, Jessica
Girardi, Enrico
Nicastri, Emanuele
Maggi, Fabrizio
Antinori, Andrea
Mazzotta, Valentina
,
Al Moghazi, Samir
Andreoni, Massimo
Bevilacqua, Nazario
Biliotti, Elisa
Blanc, Pierluigi
Bruno, Raffaele
Caraffa, Emanuela
Cascio, Antonio
Cattelan, Anna Maria
Cauda, Roberto
Carletti, Fabrizio
Cerva, Carlotta
Corpolongo, Angela
D’Abramo, Alessandra
De Zottis, Federico
Di Bari, Silvia
Di Perri, Giovanni
Di Pietro, Massimo
Donno, Davide Roberto
Faraglia, Francesca
Gavaruzzi, Francesca
Gentile, Ivan
Giancola, Maria Letizia
Giombini, Emanuela
Gori, Andrea
Grossi, Paolo
Gruber, Cesare Ernesto Maria
Iacobello, Carmelo
Iaria, Chiara
Libanore, Marco
Libertone, Raffaella
Lichtner, Miriam
Loiacono, Laura
Mariano, Andrea
Massari, Marco
Mastroianni, Claudio Maria
Meschi, Silvia
Milozzi, Eugenia
Mussini, Cristina
Parrella, Roberto
Puoti, Massimo
Rizzardini, Giuliano
Saracino, Annalisa
Scorzolini, Laura
Specchiarello, Eliana
Tavio, Marcello
Torti, Carlo
Viale, Pierluigi
Vita, Serena
Vittozzi, Pietro
-
Funding
Funding for this research was provided by:
HORIZON EUROPE Framework Programme (101046016)
Italian Drug Agency (AIFA) and by the Italian Ministry of Health (Ricerca Corrente Linea 1)
- License Information
-
More Information
Article History
Received: 7 March 2025
Accepted: 8 August 2025
First Online: 18 August 2025
Declarations
:
: The authors declare no competing interests.
: All included individuals have signed a written informed consent to participate in the study. The study protocol and the informed consent were approved by the Scientific Committee of the Italian Medicines Agency (AIFA) and by the Ethical Committee of the National Institute for Infectious Diseases “Lazzaro Spallanzani” in Rome, Italy, as National Review Board for COVID-19 pandemic in Italy (approval number: n. 380, 30/09/2021. FAV del Registro delle Sperimentazioni 2020/2021).
